Position in FTRE
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$8,927,786
-$4,952,443 QoQ
Shares Held
947,748
+17.8% QoQ
Ownership
1.00%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 97.29358437052888.ToString("F0")%
Shared 0.ToString("F0")%
None 2.7064156294711252.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BECK MACK & OLIVER LLC holds $9,329,473 across 3 Biotechnology names. FTRE ranks #1 (95.7% of the industry book) .
All Filings in FTRE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,927,786 | 947,748 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $13,880,229 | 804,651 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $11,819,356 | 1,403,724 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,973,524 | 2,018,932 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $22,229,548 | 2,944,311 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $22,160,088 | 2,935,111 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $105,111,325 | 5,635,996 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $117,067,980 | 5,853,399 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $82,553,650 | 3,537,003 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $95,060,029 | 2,368,212 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $74,326,913 | 2,129,711 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $58,078,383 | 2,031,423 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $901,265 | 26,500 | Shares | Sole | 2023-08-08 | |
| No filing history on record for this holder in this stock. | ||||||